EudraCT Number: 2017-003757-41 Sponsor Protocol Number: CCP-020-302 Start Date: 2018-02-19
Sponsor Name: Castle Creek Pharmaceuticals, LLC
Full Title: An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)
Medical condition: Epidermolysis Bullosa Simplex (EBS)
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10014989 Epidermolysis bullosa PT
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) AT (Completed) NL (Ongoing) DE (Completed) FR (Completed)
Trial results: View results

EudraCT Number: 2019-003158-10 Sponsor Protocol Number: 212358 Start Date: 2020-06-04
Sponsor Name: GlaxoSmithKline Research & Development Ltd
Full Title: Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants with Primary Biliary Cholangitis
Medical condition: Moderate to Severe Pruritus (itching) caused by primary biliary cholangitis (PBC)
Disease: Version SOC Term Classification Code Term Level
21.1 10040785 - Skin and subcutaneous tissue disorders 10064190 Cholestatic pruritus PT
21.0 10019805 - Hepatobiliary disorders 10080429 Primary biliary cholangitis PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Ongoing) PL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2020-000306-29 Sponsor Protocol Number: 20103 Start Date: 2020-06-01
Sponsor Name: Bayer AG
Full Title: A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NY...
Medical condition: Heart failure
Disease: Version SOC Term Classification Code Term Level
20.0 100000004849 10019279 Heart failure LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Ongoing) DK (Ongoing) HU (Ongoing) BG (Ongoing) PT (Ongoing) GR (Ongoing) FI (Ongoing)
Trial results: (No results available)